On the Desk Talking All Things Risk

On the Desk Talking All Things Risk

With the market volatility spiking, the boys take the opportunity to talk about all things Risk. Delving in to what it means to them, personal risk tolerances, risk measurement and management. Sign up for a free trial to get full access to expert insights and independent stock market  research.

Read more
On The Desk - Talking Alternative Investments

On the Desk Talking Alternative Investments

This week “on the desk” Chris, Tom and Ben discuss the merits of alternative investments, particularly narrowing in on their thoughts and experiences with collectibles, equity crowdfunding, and cryptocurrencies.   Why not sign up for a free trial? Get access to expert insights and independent research and become a better investor.

Read more

BUY HOLD SELL – Imugene (ASX: IMU)

Imugene (IMU) is expected to move into the ASX 200 in the December quarter rebalance. If that happens, fund managers that are benchmarked to the ASX 200 index must consider buying it, and passive funds have to buy it. It also puts the company on the radar of more investors and research houses. For some…

Read more